29 March 2000 First experience of photodithazine clinical application for photodynamic therapy of malignant tumors
Author Affiliations +
Proceedings Volume 3909, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy IX; (2000) https://doi.org/10.1117/12.379891
Event: BiOS 2000 The International Symposium on Biomedical Optics, 2000, San Jose, CA, United States
Abstract
In 1998 a new second-generation photosensitizer was introduced in Russia - a chlorine derivative named Photodithazine - water-soluble preparation with absorption peak at 668 nm. This novel preparation has passed pre- clinical in vitro and in vivo studies. In 1999 a limited series of clinical testing of photodynamic therapy with photodithazine has been performed in the State Research Center for Laser Medicine of Russian Ministry of Public Health.
© (2000) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Eugeny Ph. Stranadko, Eugeny Ph. Stranadko, Gelii V. Ponomarev, Gelii V. Ponomarev, V. M. Mechkov, V. M. Mechkov, M. V. Ryabov, M. V. Ryabov, Andrei V. Ivanov, Andrei V. Ivanov, Andrei V. Reshetnickov, Andrei V. Reshetnickov, U. M. Koraboyev, U. M. Koraboyev, } "First experience of photodithazine clinical application for photodynamic therapy of malignant tumors", Proc. SPIE 3909, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy IX, (29 March 2000); doi: 10.1117/12.379891; https://doi.org/10.1117/12.379891
PROCEEDINGS
7 PAGES


SHARE
Back to Top